Amifampridine

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Amifampridine and local guidelines before prescribing.

Potassium-channel blocker

Mechanism

Potassium-channel blocker.

Uses

Lambert-Eaton myasthenic syndrome.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Paraesthesia, seizures, nausea, arrhythmia.

Interactions

QT-prolonging drugs.

Contraindications and cautions

Epilepsy

Monitoring

ECG

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

Reduce dose in renal and hepatic impairment

Overdose and reversal

Supportive

Special advice

ECG monitoring.

More from the textbook: uses, cautions and other points
Where it is discussed in the book